T. Rowe Price Associates’s Confluent CFLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-260,326
| Closed | -$7.87M | – | 3145 |
|
|
2025
Q4 | $7.87M | Sell |
260,326
-115,384
| -31% | -$2.83M | ﹤0.01% | 1280 |
|
|
2025
Q3 | $7.44M | Sell |
375,710
-3,086,316
| -89% | -$64.5M | ﹤0.01% | 1297 |
|
|
2025
Q2 | $86.3M | Sell |
3,462,026
-2,048,717
| -37% | -$46.2M | 0.01% | 601 |
|
|
2025
Q1 | $129M | Buy |
5,510,743
+654,827
| +13% | +$19M | 0.02% | 511 |
|
|
2024
Q4 | $136M | Sell |
4,855,916
-973,153
| -17% | -$26.1M | 0.02% | 503 |
|
|
2024
Q3 | $119M | Sell |
5,829,069
-11,124,418
| -66% | -$249M | 0.01% | 531 |
|
|
2024
Q2 | $501M | Sell |
16,953,487
-628,427
| -4% | -$18.1M | 0.06% | 266 |
|
|
2024
Q1 | $537M | Buy |
17,581,914
+2,587,169
| +17% | +$73M | 0.07% | 266 |
|
|
2023
Q4 | $351M | Buy |
14,994,745
+3,870,881
| +35% | +$93.5M | 0.05% | 313 |
|
|
2023
Q3 | $329M | Sell |
11,123,864
-1,454,323
| -12% | -$48.7M | 0.05% | 304 |
|
|
2023
Q2 | $444M | Buy |
12,578,187
+101,267
| +0.8% | +$2.83M | 0.06% | 266 |
|
|
2023
Q1 | $300M | Buy |
12,476,920
+1,938,668
| +18% | +$45M | 0.05% | 316 |
|
|
2022
Q4 | $234M | Buy |
10,538,252
+1,112,771
| +12% | +$25.8M | 0.04% | 345 |
|
|
2022
Q3 | $224M | Sell |
9,425,481
-498,227
| -5% | -$13.4M | 0.04% | 340 |
|
|
2022
Q2 | $231M | Sell |
9,923,708
-765,068
| -7% | -$20.6M | 0.03% | 444 |
|
|
2022
Q1 | $438M | Buy |
10,688,776
+7,559,801
| +242% | +$394M | 0.04% | 353 |
|
|
2021
Q4 | $239M | Buy |
3,128,975
+1,209,830
| +63% | +$87.2M | 0.02% | 515 |
|
|
2021
Q3 | $114M | Buy |
1,919,145
+568,959
| +42% | +$29.6M | 0.01% | 723 |
|
|
2021
Q2 | $64.1M | Buy |
+1,350,186
| New | +$65.3M | 0.01% | 946 |
|
Other funds holding CFLT
SWA
IA
HNB
T. Rowe Price Associates's CFLT Position: Q1 2026 in Review
T. Rowe Price Associates sold out of Confluent (CFLT) in Q1 2026, closing a stake of 260,326 shares — an estimated $7.87M sold.
T. Rowe Price Associates first reported a position in CFLT in Q2 2021 and held it in 19 quarters. The position peaked at $537M in Q1 2024. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.
- T. Rowe Price Associates reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
- T. Rowe Price Associates sold 260,326 Confluent shares in Q1 2026, an estimated $7.87M.
- T. Rowe Price Associates first reported a position in Confluent in Q2 2021 and held it in 19 quarters.
- T. Rowe Price Associates's Confluent position peaked at $537M in Q1 2024.
- 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.